Heartflow (HTFL) Cash from Financing Activities (2024 - 2025)

Heartflow's (HTFL) quarterly Cash from Financing Activities came in at -$50000.0 in Q4 2025, down 105.88% year-on-year from $851000.0 in Q4 2024, and down 100.02% quarter-over-quarter from $214.9 million in Q3 2025.

Heartflow (HTFL) Cash from Financing Activities (2024 - 2025) Analysis & Trends

Heartflow's Cash from Financing Activities history runs 2 years deep, the most recent figure standing at -$50000.0 for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities fell 105.88% year-over-year to -$50000.0 in Q4 2025; TTM through Dec 2025 was $216.7 million, a N/A change from a year earlier, with the FY2025 full-year figure at $286.0 million, up 12686.9% from the prior year.
  • Cash from Financing Activities retreated to -$50000.0 in Q4 2025 per HTFL's latest filing, from $214.9 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $214.9 million in Q3 2025 and bottomed at -$50000.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Veeva Systems 29.34 Bn 22.03 Bn 662.02 Mn -262.53 Mn
2 BrightSpring Health Services 13.49 Bn 12.59 Bn 482.22 Mn -70.02 Mn
3 Healthequity 7.96 Bn 7.70 Bn 256.31 Mn -137.18 Mn
4 10x Genomics 6.17 Bn 5.63 Bn 106.18 Mn -8.42 Mn
5 Hinge Health 6.02 Bn 5.70 Bn 154.23 Mn -112.85 Mn
6 MiniMed 4.19 Bn 3.89 Bn 480.00 Mn 512.00 Mn
7 Waystar Holding 4.14 Bn 4.07 Bn 216.84 Mn 13.46 Mn
8 Doximity 3.82 Bn 3.08 Bn 125.97 Mn -93.16 Mn
9 Privia Health 3.10 Bn 2.73 Bn - -10.67 Mn
10 Heartflow 906.97 Mn 730.19 Mn 39.06 Mn -50,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -50,000.00
Dec 31, 2025 -50,000.00
Sep 30, 2025 214.94 Mn
Sep 30, 2025 214.94 Mn
Dec 31, 2024 851,000.00
Dec 31, 2024 851,000.00
Sep 30, 2024 983,000.00
Sep 30, 2024 983,000.00